153 related articles for article (PubMed ID: 26826045)
1. HPV vaccine introduction in Rwanda: Impacts on the broader health system.
Torres-Rueda S; Rulisa S; Burchett HE; Mivumbi NV; Mounier-Jack S
Sex Reprod Healthc; 2016 Mar; 7():46-51. PubMed ID: 26826045
[TBL] [Abstract][Full Text] [Related]
2. Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systems in African countries through HPV vaccine introduction.
Dochez C; Burnett RJ; Mbassi SM; Were F; Musyoki A; Trovoada D; Mphahlele MJ
Papillomavirus Res; 2017 Dec; 4():66-71. PubMed ID: 29179872
[TBL] [Abstract][Full Text] [Related]
3. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
[TBL] [Abstract][Full Text] [Related]
4. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
Abdullahi LH; Hussey GD; Wiysonge CS; Kagina BM
S Afr Med J; 2020 May; 110(6):525-531. PubMed ID: 32880566
[TBL] [Abstract][Full Text] [Related]
5. National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation.
Mphuru A; Li AJ; Kyesi F; Mwengee W; Mazige F; Nshunju R; Shayo B; Giattas MR; Loharikar A; Lyimo D
Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A2-A9. PubMed ID: 33962839
[TBL] [Abstract][Full Text] [Related]
6. Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019.
Li AJ; Manzi F; Kyesi F; Makame Y; Mwengee W; Fleming M; Mkopi A; Mmbaga S; Lyimo D; Loharikar A
Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A38-A48. PubMed ID: 34229889
[TBL] [Abstract][Full Text] [Related]
7. HPV vaccination strategies targeting hard-to-reach populations: Out-of-school girls in LMICs.
Bonner K; Banura C; Basta NE
Vaccine; 2018 Jan; 36(2):191-193. PubMed ID: 29198915
[No Abstract] [Full Text] [Related]
8. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
[TBL] [Abstract][Full Text] [Related]
9. Do parental education and income matter? A nationwide register-based study on HPV vaccine uptake in the school-based immunisation programme in Norway.
Feiring B; Laake I; Molden T; Cappelen I; Håberg SE; Magnus P; Steingrímsdóttir ÓA; Strand BH; Stålcrantz J; Trogstad L
BMJ Open; 2015 May; 5(5):e006422. PubMed ID: 25991445
[TBL] [Abstract][Full Text] [Related]
10. The impact of introducing new vaccines on the health system: case studies from six low- and middle-income countries.
Burchett HE; Mounier-Jack S; Torres-Rueda S; Griffiths UK; Ongolo-Zogo P; Rulisa S; Edengue JM; Chavez E; Kitaw Y; Molla M; Konate M; Gelmon L; Onyango-Ouma W; Lagarde M; Mills A
Vaccine; 2014 Nov; 32(48):6505-12. PubMed ID: 25261379
[TBL] [Abstract][Full Text] [Related]
11. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
Watson M; Shaw D; Molchanoff L; McInnes C
Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India-2018-2019.
Ahmed D; VanderEnde K; Harvey P; Bhatnagar P; Kaur N; Roy S; Singh N; Denzongpa P; Haldar P; Loharikar A
Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A17-A25. PubMed ID: 34429233
[TBL] [Abstract][Full Text] [Related]
13. National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learned.
Casey RM; Adrien N; Badiane O; Diallo A; Loko Roka J; Brennan T; Doshi R; Garon J; Loharikar A
Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A10-A16. PubMed ID: 34593269
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys.
Sayinzoga F; Tenet V; Heideman DAM; Sibomana H; Umulisa MC; Franceschi S; Hakizimana JD; Clifford GM; Baussano I
Lancet Glob Health; 2023 Jul; 11(7):e1096-e1104. PubMed ID: 37207683
[TBL] [Abstract][Full Text] [Related]
15. Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents.
Hansen BT; Campbell S; Burger E; Nygård M
Prev Med; 2015 Aug; 77():4-10. PubMed ID: 25944266
[TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project - Botswana, 2013.
Raesima MM; Forhan SE; Voetsch AC; Hewitt S; Hariri S; Wang SA; Pelletier AR; Letebele M; Pheto T; Ramogola-Masire D; El-Halabi S
MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(40):1147-9. PubMed ID: 26468997
[TBL] [Abstract][Full Text] [Related]
17. High uptake of HPV immunisation in Scotland--perspectives on maximising uptake.
Potts A; Sinka K; Love J; Gordon R; McLean S; Malcolm W; Ross D; Donaghy M
Euro Surveill; 2013 Sep; 18(39):. PubMed ID: 24094062
[TBL] [Abstract][Full Text] [Related]
18. The impact of a human papillomavirus (HPV) vaccination campaign on routine primary health service provision and health workers in Tanzania: a controlled before and after study.
Gallagher KE; Erio T; Baisley K; Lees S; Watson-Jones D
BMC Health Serv Res; 2018 Mar; 18(1):173. PubMed ID: 29530042
[TBL] [Abstract][Full Text] [Related]
19. Achieving high and equitable coverage of adolescent HPV vaccine in Scotland.
Sinka K; Kavanagh K; Gordon R; Love J; Potts A; Donaghy M; Robertson C
J Epidemiol Community Health; 2014 Jan; 68(1):57-63. PubMed ID: 23986492
[TBL] [Abstract][Full Text] [Related]
20. The effects of a brief educational intervention on human papillomavirus knowledge and intention to initiate HPV vaccination in 18-26 year old young adults.
Kester LM; Shedd-Steele RB; Dotson-Roberts CA; Smith J; Zimet GD
Gynecol Oncol; 2014 Mar; 132 Suppl 1():S9-12. PubMed ID: 24384459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]